G R Greenberg

Author PubWeight™ 140.13‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 2001 11.12
2 Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators. N Engl J Med 1995 4.56
3 Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis. Gut 2010 4.50
4 THE ANEMIA OF INFECTION. III. THE UPTAKE OF RADIO-ACTIVE IRON IN IRON-DEFICIENT AND IN PYRIDOXINE-DEFICIENT PIGS BEFORE AND AFTER ACUTE INFLAMMATION. J Clin Invest 1947 3.73
5 Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000 3.52
6 A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. N Engl J Med 2000 2.78
7 A prospective cohort study to determine the relationship between serum infliximab concentration and efficacy in patients with luminal Crohn's disease. Aliment Pharmacol Ther 2014 2.18
8 Evidence for a complex regulating the in vivo activities of early enzymes induced by bacteriophage T4. J Biol Chem 1974 1.87
9 Characteristics of the deo operon: role in thymine utilization and sensitivity to deoxyribonucleosides. J Bacteriol 1968 1.68
10 Albumin, fibrinogen and transferrin synthesis in isolated rat hepatocyte suspensions. A model for the study of plasma protein synthesis. Biochem J 1975 1.66
11 A new assay of thymidylate synthetase activity based on the release of tritium from deoxyuridylate-5-3-H. J Biol Chem 1967 1.64
12 HYDROXYMETHYLDEOXYCYTIDYLATE KINASE FORMATION AFTER BACTERIOPHAGE INFECTION OF ESCHERICHIA COLI. Proc Natl Acad Sci U S A 1959 1.63
13 Evidence for a possible direct role of dCMP hydroxymethylase in T4 phage DNA synthesis. Cold Spring Harb Symp Quant Biol 1968 1.51
14 Metabolic studies in total parenteral nutrition with lipid in man. Comparison with glucose. J Clin Invest 1976 1.45
15 Protein-sparing therapy in postoperative patients. Effects of added hypocaloric glucose or lipid. N Engl J Med 1976 1.44
16 Direct participation of dCMP hydroxymethylase in synthesis of bacteriophage T4 DNA. Proc Natl Acad Sci U S A 1973 1.44
17 Total enteral nutrition support improves body composition of patients with active Crohn's disease. JPEN J Parenter Enteral Nutr 1995 1.40
18 Inhibition of pancreas and gallbladder by pancreatic polypeptide. Lancet 1978 1.39
19 Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr 1977 1.36
20 Review article: a clinician's guide for therapeutic drug monitoring of infliximab in inflammatory bowel disease. Aliment Pharmacol Ther 2013 1.32
21 Celiac disease and spinocerebellar degeneration with normal vitamin E status. Neurology 1985 1.28
22 Interaction of vasoactive intestinal peptide with mouse lymphocytes: specific binding and the modulation of mitogen responses. J Immunol 1984 1.28
23 Effect of the folic acid analogue, trimethoprim, on growth, macromolecular synthesis, and incorporation of exogenous thymine in Escherichia coli. J Bacteriol 1972 1.23
24 Quality of life, nutritional status, and gastrointestinal hormone profile following the Whipple procedure. Am J Surg 1995 1.20
25 Incorporation of fatty acids containing photosensitive groups into phospholipids of Escherichia coli. Proc Natl Acad Sci U S A 1976 1.19
26 Loss of an essential function of Escherichia coli by deletions in the thyA region. J Bacteriol 1973 1.17
27 Tetrahydrofolate-dependent labilization of the hydrogen atom on carbon 5 of 5'-deoxycytidylate, a step in the deoxycytidylate hydroxymethylase reaction. J Biol Chem 1967 1.16
28 Galanin inhibits insulin secretion and induces hyperglycemia in dogs. Diabetes 1985 1.12
29 Duodenal pH in health and duodenal ulcer disease: effect of a meal, Coca-Cola, smoking, and cimetidine. Gut 1984 1.11
30 Effect of total parenteral nutrition on gut hormone release in humans. Gastroenterology 1981 1.10
31 Total parenteral nutrition and complete bowel rest in the management of Crohn's disease. JPEN J Parenter Enteral Nutr 1985 1.10
32 Rice varieties with similar amylose content differ in starch digestibility and glycemic response in humans. Am J Clin Nutr 1991 1.10
33 Regulation of deoxyribonucleotide biosynthesis during in vivo bacteriophage T4 DNA replication. Intrinsic control of synthesis of thymine and 5-hydroxymethylcytosine deoxyribonucleotides at precise ratio found in DNA. J Biol Chem 1977 1.09
34 Treatment of ulcerative colitis with oral 5-aminosalicylic acid including patients with adverse reactions to sulfasalazine. Am J Gastroenterol 1988 1.08
35 Concerns of patients with inflammatory bowel disease: results from a clinical population. Am J Gastroenterol 2001 1.08
36 Characteristics of a bacteriophage T4-induced complex synthesizing deoxyribonucleotides. J Biol Chem 1982 1.06
37 On the defect of a dCMP hydroxymethylase mutant of bacteriophage T4 showing enzyme activity in extracts. Biochem Biophys Res Commun 1973 1.04
38 A temperature-sensitive thy mutant blocked in the synthesis of thymidylate synthetase. J Biol Chem 1971 1.04
39 Simultaneous initiation of synthesis of bacteriophage T4 DNA and of deoxyribonucleotides. Proc Natl Acad Sci U S A 1976 1.03
40 New dUTPase and dUDPase activites after infection of Escherichia coli by T2 bacteriophage. Proc Natl Acad Sci U S A 1966 1.01
41 Eruptive tufted angiomas in a patient with Crohn's disease. J Clin Pathol 2005 1.01
42 Effects of gastrointestinal hormones on fasting gallbladder storage patterns in man. Eur J Clin Invest 1979 1.00
43 Diagnostic misclassification reduces the ability to detect linkage in inflammatory bowel disease genetic studies. Gut 2001 0.99
44 An exchange between the hydrogen atom on carbon 5 of deoxyuridylate and water catalyzed by thymidylate synthetase. J Biol Chem 1967 0.98
45 Combination ciprofloxacin and metronidazole for active Crohn's disease. Can J Gastroenterol 1998 0.97
46 Small intestinal transplantation using cyclosporine. Report of a case. Transplantation 1986 0.96
47 Genetic mapping of a mutation in Escherichia coli showing reduced activity of thymidine phosphorylase. J Bacteriol 1967 0.96
48 Operative and environmental risk factors for recurrence of Crohn's disease. Int J Colorectal Dis 1999 0.96
49 The adaptation of the small intestine after resection in response to free fatty acids. Am J Clin Nutr 1984 0.95
50 Preliminary report on the Mount Sinai Hospital Inflammatory Bowel Disease Genetics Project. Dis Colon Rectum 1997 0.94
51 Replicative bacteriophage DNA synthesis in plasmolyzed T4-infected cells: evidence for two independent pathways to DNA. J Virol 1976 0.93
52 Release of VIP, secretin and motilin after duodenal acidification in man. Acta Hepatogastroenterol (Stuttg) 1978 0.93
53 Gastric acid regulates the release of plasma secretin in man. Eur J Clin Invest 1982 0.93
54 Identification of bacteriophage T4 gene 60 product and a role for this protein in DNA topoisomerase. J Biol Chem 1983 0.91
55 Pharmacokinetics of pancreatic polypeptide in man. Gut 1978 0.91
56 Oral 5-aminosalicylic acid for inflammatory bowel disease in pregnancy: safety and clinical course. Gastroenterology 1993 0.91
57 Total sequence, flanking regions, and transcripts of bacteriophage T4 nrdA gene, coding for alpha chain of ribonucleoside diphosphate reductase. J Biol Chem 1988 0.90
58 Bacteriophage T4 nrdA and nrdB genes, encoding ribonucleotide reductase, are expressed both separately and coordinately: characterization of the nrdB promoter. J Bacteriol 1990 0.90
59 Mechanisms coordinating gastric and small intestinal MMC: role of extrinsic innervation rather than motilin. Am J Physiol 1994 0.89
60 Mutagenic effect of temperature-sensitive mutants of gene 42 (dCMP hydroxymethylase) of bacteriophage T4. J Virol 1973 0.89
61 Effect of bacteriophage T4 nrd mutants on deoxyribonucleotide synthesis in vivo. J Biol Chem 1980 0.88
62 Health-related concerns of people who receive psychological support for inflammatory bowel disease. Can J Gastroenterol 1998 0.88
63 Functional monitors of rejection in small intestinal transplants. Am J Surg 1984 0.87
64 Properties of Bacteriophage T4 ribonucleoside diphosphate reductase subunits coded by nrdA and nrdB mutants. J Biol Chem 1983 0.87
65 Comparison of amino acid v peptide based enteral diets in active Crohn's disease: clinical and nutritional outcome. Gut 1994 0.87
66 Effect of pancreatic polypeptide on DNA-synthesis in the pancreas. Experientia 1977 0.87
67 Fiberoptic endoscopy during laparotomy in the diagnosis of small intestinal bleeding. Gastroenterology 1976 0.86
68 Relationship between porcine motilin-induced migrating motor complex-like activity, vagal integrity, and endogenous motilin release in dogs. Gastroenterology 1984 0.86
69 Ultrastructural and functional studies of cultured hepatocytes. Lab Invest 1974 0.86
70 Sulfasalazine and mesalazine for the maintenance therapy of Crohn's disease: a meta-analysis. Am J Gastroenterol 1994 0.85
71 Intravenous protein-sparing therapy in patients with gastrointestinal disease. JPEN J Parenter Enteral Nutr 1980 0.85
72 Specific binding of vasoactive intestinal peptide to human circulating mononuclear cells. Can J Physiol Pharmacol 1983 0.85
73 Quality of life rapidly improves with budesonide therapy for active Crohn's disease. Canadian Inflammatory Bowel Disease Study Group. Inflamm Bowel Dis 2000 0.85
74 Risk and significance of endoscopic/radiological evidence of recurrent Crohn's disease. Gastroenterology 1997 0.84
75 Critical assessment of body-composition measurements in malnourished subjects with Crohn's disease: the role of bioelectric impedance analysis. Am J Clin Nutr 1994 0.83
76 Vagal control of migrating motor complex-related peaks in canine plasma motilin, pancreatic polypeptide, and gastrin. Can J Physiol Pharmacol 1983 0.83
77 Inhibition of secretin stimulated pancreatic secretion by pancreatic polypeptide. Gut 1979 0.83
78 Effect of bovine pancreatic polypeptide on basal pancreatic and biliary outputs in man. Dig Dis Sci 1979 0.83
79 The acute effect of fat on insulin secretion. J Clin Endocrinol Metab 1988 0.83
80 Relationship of postprandial motilin, gastrin, and pancreatic polypeptide release to intestinal motility during vagal interruption. Can J Physiol Pharmacol 1992 0.82
81 Truncated and full-length glucagon-like peptide-1 (GLP-1) differentially stimulate intestinal somatostatin release. Endocrine 1997 0.81
82 Diagnosis of Meckel's diverticulum in adults. Mt Sinai J Med 1984 0.81
83 Effect of pancreatic polypeptide on canine migrating motor complex and plasma motilin. Am J Physiol 1983 0.81
84 Cholecystokinin type A receptors mediate intestinal fat-induced inhibition of acid secretion through somatostatin-14 in dogs. Endocrinology 1994 0.81
85 Conditions allowing synthesis of thymidylate synthetase at the nonpermissive temperature in a temperature-sensitive thy mutant normally blocked in its translation. J Biol Chem 1971 0.81
86 Temperature-sensitive revertants. Biochem Biophys Res Commun 1971 0.81
87 Effects of pancreatic polypeptide on motilin and circulating metabolites in man. Eur J Clin Invest 1980 0.80
88 Intragenic complementation between temperature-sensitive mutants of gene 42 (dCMP hydroxymethylase) of bacteriophage T4. J Virol 1973 0.80
89 Effect of bovine pancreatic polypeptide on gastric acid and pepsin output in man. Acta Hepatogastroenterol (Stuttg) 1978 0.80
90 Effect of bacteriophage T4 DNA topoisomerase gene 39 on level of beta chain of ribonucleoside diphosphate reductase in a T4 nrdB mutant. J Biol Chem 1988 0.80
91 High affinity specific binding of vasoactive intestinal peptide to human circulating T cells, B cells and large granular lymphocytes. J Neuroimmunol 1990 0.79
92 Role of bacteriophage T4 DNA-delay gene products in deoxyribonucleotide synthesis. J Biol Chem 1980 0.79
93 Apparent mutagenic effect of induction of lambda prophage inserted between lysA and thyA. J Bacteriol 1974 0.79
94 Effect of low dose secretin and caerulein on pure pancreatic bicarbonate secretion and plasma secretin in man. Acta Hepatogastroenterol (Stuttg) 1979 0.78
95 Paracellular recirculation of sodium is essential to support nutrient absorption in the gastrointestinal tract: an hypothesis. Clin Invest Med 1986 0.78
96 Defect in synthesis of deoxyribonucleotides by a bacteriophage T4 nrdB mutant is suppressed on mutation of T4 DNA topoisomerase gene. J Biol Chem 1988 0.78
97 Characterization of somatostatin receptor subtypes mediating inhibition of nutrient-stimulated gastric acid and gastrin in dogs. Regul Pept 1997 0.78
98 Glucagon-like peptide-1-(7-36) amide and peptide YY mediate intraduodenal fat-induced inhibition of acid secretion in dogs. Endocrinology 1998 0.78
99 Insecure attachment in a subgroup with ulcerative colitis defined by ANCA status. Dig Dis Sci 2000 0.78
100 Vagal control of fasting somatostatin levels. Neurogastroenterol Motil 1995 0.78
101 Effect of vagal blockade on food- and hormone-stimulated release of pancreatic polypeptide and motilin in dogs. Dig Dis Sci 1985 0.78
102 Lack of effect of pancreatic polypeptide in the rate of gastric emptying and gut hormone release during breakfast. Digestion 1981 0.78
103 Relationship between social support and autonomic function during a stress protocol in ulcerative colitis patients in remission. Inflamm Bowel Dis 2011 0.78
104 Role of deoxycytidylate deaminase in deoxyribonucleotide synthesis in bacteriophage T4 DNA replication. J Biol Chem 1977 0.77
105 Somatostatin-14 modulates acid-dependent inhibition of meal-stimulated gastrin via muscarinic pathways in dogs. Regul Pept 1998 0.77
106 The impact of ulcerative colitis is greater in unmarried and young patients. Can J Gastroenterol 2007 0.77
107 The role of vagal integrity in gastrin releasing peptide stimulated gastroenteropancreatic hormone release and gastric acid secretion. Regul Pept 1985 0.77
108 Partial purification of stable transcription complexes with cloned tRNA genes of Drosophila melanogaster. J Biol Chem 1985 0.77
109 Regulation of peptide-YY synthesis and secretion in fetal rat intestinal cultures. Endocrinology 1991 0.77
110 Synthesis and secretion of somatostatin-28 and -14 by fetal rat intestinal cells in culture. Am J Physiol 1990 0.77
111 Review and clinical perspectives for the use of infliximab in ulcerative colitis. Can J Gastroenterol 2008 0.77
112 Plasma-secretin during fasting. Lancet 1978 0.77
113 Inhibitory effect of agents altering the structure of DNA on the synthesis of pyrimidine deoxyribonucleotides in bacteriophage T4 DNA replication. J Biol Chem 1977 0.77
114 Nutrient and peptide regulation of somatostatin-28 secretion from intestinal cultures. Endocrinology 1998 0.77
115 Effect of intervention in inflammatory bowel disease on health-related quality of life: a critical review. Dis Colon Rectum 1995 0.76
116 Somatostatin receptor subtype-5 mediates inhibition of peptide YY secretion from rat intestinal cultures. Am J Physiol Gastrointest Liver Physiol 2000 0.76
117 Endogenous acid releases secretin in man. Acta Hepatogastroenterol (Stuttg) 1977 0.76
118 Carrier rate of APC I1307K is not increased in inflammatory bowel disease patients of Ashkenazi Jewish origin. Hum Genet 2001 0.75
119 Cimetidine-resistant Zollinger-Ellison syndrome: successful management with ranitidine. Can Med Assoc J 1983 0.75
120 Tandem cloning of bacteriophage T4 nrdA and nrdB genes and overproduction of ribonucleoside diphosphate reductase (alpha 2 beta 2) and a mutationally altered form (alpha 2 beta 2(93)). J Bacteriol 1992 0.75
121 How to assess the physiological role of a new peptide hormone: pancreatic polypeptide infusion in man [proceedings]. J Endocrinol 1979 0.75
122 The effect of a time delay on the characteristics of the canine glucoregulatory system. Metabolism 1990 0.75
123 Calcitonin gene-related peptide-I preferentially stimulates secretion of somatostatin from intestinal cultures. Endocrinology 1993 0.75
124 How laboratory dogs accommodate meals of different size but similar composition. Am J Physiol 1985 0.75
125 The release profile of a controlled release preparation of 5-aminosalicylic acid (Rowasa I) in humans. Dis Colon Rectum 1990 0.75
126 Proceedings: Plasma protein synthesis in isolated hepatocyte cultures. Clin Sci Mol Med 1974 0.75
127 The effect of galanin on canine plasma glucose and gastroenteropancreatic hormone responses to oral nutrients and intravenous arginine. Endocrinology 1986 0.75
128 Effect of exercise on the pancreatic polypeptide response to food in man. Horm Metab Res 1986 0.75
129 Consequences of enteral nutrition therapy on body composition changes in acute Crohn's disease. Basic Life Sci 1993 0.75
130 Parotid secretion patterns during meals and their relationships to the tonicity of body fluids and to gastrin and pancreatic polypeptide in sheep. Br J Nutr 1990 0.75
131 Neuro-hormonal control of pancreatic function in man and its failure. Scand J Gastroenterol Suppl 1983 0.75
132 [Conversion of C8 of guanine to a l carbon unit during biosynthesis of riboflavin]. Bull Soc Chim Biol (Paris) 1969 0.75
133 The metabolic and hormonal adaptations of normal dogs to long-term exogenous sulfated insulin infusions. Metabolism 1986 0.75
134 [Effect of trimebutine on the plasma postprandial release of gastrointestinal hormones in the dog]. Gastroenterol Clin Biol 1987 0.75
135 Metabolic control in diabetic dogs treated with pancreatic autotransplants and insulin pumps. Diabetes 1986 0.75